June 2018 Question of the Month
Do you feel that disclosing the list price of prescription drugs during DTC ads will decrease patient demand for certain products?
Yes: 14.3%
No: 85.7%
Poll Results
March 2019 Question of the Month
How will the HHS proposed rule changes to Medicare Part D and Medicaid drug rebate safe harbors impact pharmaceutical product net costs for PBMs?
Higher net costs after the implementation of the proposed rule: 50%
Lower net costs after the implementation of the proposed rule: 12.5%
No impact, net costs will be at the same levels as today: 37.5%
February 2019 Question of the Month
What is the likelihood brand pharmaceutical manufacturers will slow drug price increases in 2019 based on the Trump administration’s proposals?
Highly Likely: 0%
Likely: 12.5%
Unlikely: 75%
Highly Unlikely: 12.5%
January 2019 Question of the Month
Are there more challenges with the new lower priced Repatha NDC compared with the higher priced NDC?
Yes: 57.1%
No: 42.9%
Do you think brand manufacturer’s strategy to introduce a lower priced brand NDC of an existing product is going to expand in 2019?
Yes: 85.7%
No: 14.3%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
